Does age-related loss of skeletal muscle drive insulin resistance by reducing glucose disposal?

The claim that skeletal muscle is the primary site for glucose disposal and that its age-related decline drives insulin resistance is robustly supported by clinical and physiological evidence. Skeletal muscle serves as the body’s principal "metabolic sink," especially in the postprandial state.

Skeletal muscle as the primary metabolic sink

In healthy individuals, skeletal muscle is responsible for approximately 70% to 85% of all insulin-stimulated glucose disposal. This dominance is due to the tissue's large relative mass and its specialized response to insulin. While adipose tissue and other organs contribute to glucose metabolism, their role in clearing glucose from the blood under insulin stimulation is significantly smaller, typically estimated at only 5% to 10% for fat.

Impact of age-related muscle loss

As individuals age, the loss of muscle mass (sarcopenia) and strength (dynapenia) directly reduces the total volume available for glucose clearance. Research indicates that muscle mass is an independent predictor of metabolic health; for instance, longitudinal data shows that muscle mass loss correlates strongly with increased HOMA-IR (a measure of insulin resistance) and a higher risk of developing Type 2 Diabetes (OR = 0.84 per unit of mass loss). In older adults, the reduction in muscle mass is often accompanied by a decrease in capillary density and mitochondrial function, further limiting the delivery and processing of glucose.

Mechanistic drivers of insulin resistance

The transition from healthy muscle to sarcopenic muscle involves several molecular and structural shifts:

• GLUT4 Translocation: Insulin normally triggers the PI3K/Akt signaling pathway, causing a 3- to 4-fold increase in GLUT4 transporters at the cell surface. Aging can impair this signaling, reducing the efficiency of each unit of muscle.
• Lipotoxicity and Inflammation: The accumulation of intramuscular adipose tissue (IMAT) and pro-inflammatory cytokines (e.g., TNF-alpha, IL-6) interferes with insulin receptor substrate 1 (IRS-1) phosphorylation, creating a state of local and systemic insulin resistance.
• Fiber Type Shifting: Age-related atrophy often targets Type II (fast-twitch) fibers more aggressively, which have different metabolic profiles than Type I fibers, shifting the overall glucose handling capacity of the tissue.

Bottom line

Skeletal muscle is the most critical site for glucose clearance; its age-related loss reduces the body’s primary metabolic reservoir and triggers inflammatory and molecular changes that directly promote insulin resistance.